Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cca.2008.01.006PMID 18237549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism

  2007cited by this paper
• IGF-1 system, Vitamin D and blood pressure relationships

  2007cited by this paper
• Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.

  2007cited by this paper
• Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease

  2007cited by this paper
• Advanced rat mammary cancers are growth hormone dependent.

  2007cited by this paper
• Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease. effects of rhG-CSF.

  2006cited by this paper
• Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.

  2006cited by this paper
• Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.

  2006cited by this paper
• Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease

  2006cited by this paper
• IGF‐I and IGFBP‐3 polymorphisms and risk of prostate cancer

  2005cited by this paper
• CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia.

  2005cited by this paper
• Insulin‐like growth factor‐I gene polymorphism and breast cancer risk in Chinese women

  2005cited by this paper
• Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer

  2005cited by this paper
• Human phenylalanine hydroxylase is activated by H2O2: a novel mechanism for increasing the L-tyrosine supply for melanogenesis in melanocytes.

  2004cited by this paper
• Melanin-concentrating hormone and its receptor are expressed and functional in human skin.

  2002cited by this paper
• Genotype–phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene

  2002cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction.

  2002cited by this paper
• Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.

  2001cited by this paper
• Polymorphic CA repeats in the IGF-I gene and breast cancer

  2001cited by this paper
• A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

  2000cited by this paper
• Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications.

  1999cited by this paper
• Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

  1999cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis.

  1998cited by this paper
• Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.

  1998cited by this paper
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

  1998cited by this paper
• The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action.

  1996cited by this paper
• Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer

  1995cited by this paper
• Expression of Insulin‐like Growth Factor I (IGF‐I) in Nevi and Melanomas

  1994cited by this paper
• Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes.

  1991cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Interactions between Growth Hormone, Insulin-Like Growth Factor I, and Basic Fibroblast Growth Factor in

  year unknowncited by this paper

• Unraveling the Obesity Paradox: Exploring the Impact of Body Weight on Cutaneous Melanoma Prognosis in Asian Population

  2024cites this paper
• New Insights into the Link Between Melanoma and Obesity.

  2024cites this paper
• Malignes Melanom und Adipositas: eine Übersichtsarbeit

  2023cites this paper
• Malignes Melanom und Adipositas: eine Übersichtsarbeit

  2022cites this paper
• Body Mass Index and Melanoma Prognosis

  2021cites this paper
• Circulating insulin‐like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition

  2018cites this paper
• Evaluation of IGF1 serum levels in malignant melanoma and healthy subjects.

  2014cites this paper
• Insulin-like growth factor system and sporadic malignant melanoma.

  2011cites this paper
• Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma

  2011influential citation
• Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

  2009cites this paper